Insight Molecular Diagnostics (IMDX) EPS (Basic) Growth (3y) (2018 - 2026)
Insight Molecular Diagnostics (IMDX) EPS (Basic) Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 10.33% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | -6.31% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 21.74% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 5.62% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | -3.09% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 16.67% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 43.02% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 5.89% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 19.75% |
| 10 | Insight Molecular Diagnostics | 158.03 Mn | 139.50 Mn | 157,000.00 | 33.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 33.78% |
| Mar 31, 2026 | -585.45% |
| Dec 31, 2025 | -34.98% |
| Sep 30, 2025 | 40.68% |
| Jun 30, 2025 | 41.00% |
| Mar 31, 2025 | 51.18% |
| Dec 31, 2024 | 31.77% |
| Sep 30, 2024 | 31.18% |
| Jun 30, 2024 | 46.58% |
| Mar 31, 2024 | -5.78% |
| Dec 31, 2023 | 5.02% |
| Sep 30, 2023 | 26.23% |
| Jun 30, 2023 | 20.19% |
| Mar 31, 2023 | 26.00% |
| Dec 31, 2022 | 36.24% |
| Sep 30, 2022 | 6.88% |
| Jun 30, 2022 | 10.58% |
| Mar 31, 2022 | -10.43% |
| Dec 31, 2021 | -55.70% |
| Sep 30, 2021 | -26.16% |